Six years later, the true scale of the vaccines’ side effects is emerging. Yet those coping with life-changing conditions ...
The advanced melanoma market has demonstrated robust growth, expanding from $4.12 billion in 2025 to a projected $4.5 billion ...
Japan's Cabinet approved on Friday a record 56 trillion yen ($490 billion) stimulus package, including cash handouts and aid ...
Canada’s patented drug industry has established a task force with the federal government to prepare for coming trade talks ...
Two physicians with somewhat contrasting views on vaccines are among the potential candidates the Trump administration is considering as its pick to lead the U.S. Centers for Disease Control and ...
The Hearty Soul on MSN
This is why some people had blood clots from the COVID-19 vaccine and others didn't
Rare medical events draw intense attention during any mass vaccination campaign. Among COVID vaccine side effects, few ...
BioNTech`s chief executive struck a cautiously positive note, saying the vaccine it makes in a partnership with Pfizer would ...
They aren't just "pandemic stocks." ...
By Bhanvi Satija LONDON, April 1 (Reuters) - Vaccine makers Pfizer and BioNTech halted a large U.S. trial of their updated ...
After shedding expensive commercial infrastructure and pivoting to a partnership model, the company is now positioning its ...
Pfizer is by far the larger and better-established drugmaker. With a market cap of $156 billion, the pharmaceutical leader boasts a deep product portfolio across several therapeutic areas. Even with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results